UNSPSC 51372006: Methyldesorphine

This classification denotes an opioid receptor agonist with the molecular formula C18H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y460N7W76B, chemically known as morphinan-3-ol, 6,7-didehydro-4,5-epoxy-6,17-dimethyl-, (5.alpha.)- but generally known as methyldesorphine, which bears US NIH Compound Identifier 519207. European Medicines Agency schedules Methyldesorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08865MIG.

UNSPSC 51372006 Methyldesorphine is a Commodity code under which state and local governments procure pharmaceuticals and opioid-antagonist products for community health, public safety, and emergency response programs. Recent opportunities show procurement officers using this code to source naloxone (an opioid overdose reversal agent), generic multi-source pharmaceuticals, and related drug management systems rather than the precursor chemical methyldesorphine itself. The actual buying pattern reflects state health departments, counties, and cooperative purchasing alliances acquiring finished pharmaceutical products and delivery systems through competitive solicitation; the code's nominal title does not align with the tangible goods state and local agencies are currently sourcing under it.

Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with electronic bid submission required and a response deadline of July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities, with proposals due March 26, 2026 and weighted evaluation emphasizing price competitiveness at 75 percent. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 as an exploratory information-gathering mechanism for vendor capabilities in direct-to-manufacturer prescription programs serving self-insured employee group health plans and state agencies. The code shows activity across the Southeast and upper Midwest, with cooperative purchasing vehicles and health agencies as primary issuing bodies.